SecBot SecBot
144 ·Filed Sep 4, 2026

EMBC

Embecta Corp.
NEUTRAL
Impact 2/10
Horizondays Processed1mo ago SEC0001000275-26-000105
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine, small-dollar director sale of compensation shares. The filing does not indicate material insider concern, especially given recent insider buying. Monitor for actual sale execution on Form 4, but no immediate trading action is warranted.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
EMBC ▲ +1.38% at T+20d
NEUTRAL call +1.38% · α vs SPY +0.78% · entry $5.80 → $5.88
Next anchor: T+60d in 5w
Latest observation: T+36 -8.95% FF3 residual α
Entry = T+0 close
Sep 4, 2026
via day close
T+1d
-4.31%
call -4.31% · α -3.76%
$5.55
settled 7w ago
T+5d
-9.66%
call -9.66% · α -8.45%
$5.24
settled 6w ago
T+20d
+1.38%
call +1.38% · α +0.78%
$5.88
settled 23d ago
T+60d
Pending
in 5w

Price Chart

Loading chart...

Executive Summary

Director Morris Milton Mayo filed a Form 144 on September 4, 2026, indicating intent to sell 6,293 shares of Embecta Corp. common stock, valued at approximately $36,891 based on the filing date. The shares were acquired on February 7, 2024, as director compensation. This is a routine, small-dollar sale by a non-executive director and does not signal material insider concern, especially given recent insider buying activity totaling $558K over the past 30 days.

Key Facts

  • Director Morris Milton Mayo filed Form 144 to sell 6,293 shares of EMBC common stock.
  • Estimated sale value is approximately $36,891 based on the filing date.
  • Shares were acquired on February 7, 2024, as director compensation.
  • Recent insider activity over the past 30 days includes 4 buys totaling $558K.
  • Market cap is approximately $322M, making this sale about 0.01% of market cap.

Financial Impact

Proposed sale of 6,293 shares valued at approximately $36,891, representing about 0.01% of market cap.

dilution

Risk Factors

  • The sale may still be executed, adding minor sell-side pressure.
  • If additional insiders file Form 144s in the coming weeks, it could signal broader selling.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
0% bullish (9 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001000275-26-000105
Document: 0001000275-26-000105-index.html0001000275-26-000105
Document: 0001000275-26-000105.txt0001000275-26-000105
13 reports for EMBC
Performance horizon
60% Hit rate @ T+20 3 of 5 directional calls Went positive at some point 5 of 5 best @ T+5▲ +13.85%May 5, 2026
Filters
Rows
Reports for EMBC — sortable, filterable
TypeNow
Sep 22, 2026
5w ago
Institutional Cluster
BEARISH ★ 4/10
$5.59 $6.42▼ −14.85%▼ −15.41%$6.55 (−17.17%)
Sep 4, 2026
7w ago
144
NEUTRAL ★ 2/10
$5.80 $5.88▲ +1.38%▲ +0.78%$6.55 (+12.93%)
Aug 13, 2026
10w ago
Insider Cluster
BULLISH ★ 5/10
$5.11 $4.94▼ −3.33%▼ −1.58%$6.55 (+28.18%)
Aug 7, 2026
11w ago
8-K
MIXED ★ 6/10
$4.42 $5.80▲ +31.22%▲ +31.62%$6.55 (+48.19%)
Aug 7, 2026
11w ago
Press Release
NEUTRAL ★ 2/10
$4.42 $5.80▲ +31.22%▲ +31.62%$6.55 (+48.19%)
Jul 23, 2026
13w ago
Press Release
NEUTRAL ★ 1/10
$3.29 $5.23▲ +58.97%▲ +55.34%$6.55 (+99.09%)
Jun 16, 2026
19w ago
Press Release
NEUTRAL ★ 3/10
$3.09 $3.10▲ +0.32%▲ +0.12%$6.55 (+111.97%)
Jun 11, 2026
19w ago
Institutional Cluster
NEUTRAL ★ 3/10
$3.08 $3.18▲ +3.25%▲ +1.36%$6.55 (+112.66%)
May 15, 2026
23w ago
8-K
MIXED ★ 6/10
$3.14 $3.13▼ −0.32%▼ −2.44%$6.55 (+108.60%)
May 5, 2026
25w ago
8-K
BEARISH ★ 8/10
$3.90 $3.49▲ +10.51%▲ +15.47%$6.55 (−67.95%)
Showing 10 of 13

US Market Status

Market Closed — Opens in 6h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 4, 2026